Aurora Spine Gains 4th U.S. Patent for Bone Density-Matched Implants

Aurora Spine has been issued the fourth U.S. patent related to its proprietary DEXA Technology platform.

The newly issued patent (U.S. Patent No. 12,605,252 B2) is entitled “Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use.” It was granted on April 21 and bolsters the company’s intellectual property portfolio surrounding patient-specific, bone density-matched implant selection and use.

The patented technology describes methods to obtain a patient’s bone density information, including a DEXA-T score or bone density measurement, selecting an implant having a density level matched to the patient’s native bone at the implantation site, and implanting the selected device. The patent supports Aurora’s DEXA Technology platform, which was engineered to offer implants designed to better match patient bone quality, including low, mid, and high bone-density implant options.

“This fourth issued DEXA Technology patent represents another important milestone in Aurora Spine’s strategy to protect and expand our leadership in bone density-matched spinal implant innovation,” said Trent J. Northcutt, president and CEO of Aurora Spine. “DEXA Technology was created to address a real clinical challenge: patients do not all have the same bone quality. By giving surgeons implant options designed around bone density, we believe Aurora is advancing a more personalized and intelligent approach to spine surgery. Through the issuance of this patent, Aurora’s competitive position will improve and it support continued development of next-generation DEXA Technology-based implants across the company’s spinal implant portfolio.”

The technology platform was developed to improve the relationship between implant structure and patient bone quality. The company aims to help surgeons select devices that better align with the mechanical environment of each patient’s anatomy.

“This patent further validates years of research and development focused on matching implant architecture to patient bone density,” said Laszlo Garamszegi, chief technology officer of Aurora Spine. “The invention protects important methods for using bone density information to guide implant selection, which is central to our DEXA platform. We believe this approach has the potential to support better load sharing, reduce implant-related complications associated with poor bone quality, and help surgeons make more informed intraoperative decisions.”

In January, Aurora was granted two U.S. patents. The first patent (No. 12,478,411 B2) is titled “Spinal Implant for Motion Preservation or Fusion.” The patented tech covers a spinal implant architecture designed to support either motion preservation or fusion, depending on clinical application.